Ontology highlight
ABSTRACT: Background
Hematological malignancies disturb the blood, lymph nodes, and bone marrow. Taking medications for treating opportunistic infections (OIs) in these individuals may enhance the risk of medication interaction as well as adverse drug reactions.Objective
This review aims to evaluate the effectiveness of nondrug interventions in reducing OIs among patients with hematological cancers.Methods
The PubMed, CENTRAL (Cochrane Central Register of Controlled Trials), and Embase databases were searched on December 26, 2022, for all randomized controlled trials (RCTs). The primary endpoint was OIs. The quality of included studies was assessed by the Cochrane Risk-of-Bias tool.Results
A total of 6 studies were included in this review with 4 interventions: (1) typ
SUBMITTER: Muhamad NA
PROVIDER: S-EPMC10132047 | biostudies-literature | 2023 Mar
REPOSITORIES: biostudies-literature